Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of M610101 in Pediatric Atopic Dermatitis
jRCT2031260244Phase 3Recruiting
- Sponsor
- Maruho Co., Ltd.
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing M610101 with Vehicle control (2 arms). Started Jun 2026; status: recruiting.
02
Drugs
ruxolitinib cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2031260244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260244.